Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M2SYS is a private biometrics and digital transformation software company that provides identity management, eGovernment, and healthcare patient-identification solutions. The company is best known for its multimodal biometric technologies, including fingerprint, finger vein, palm vein, iris, and facial recognition, which are offered through products such as Bio-Plugin, CloudABIS, and the Hybrid Biometric Platform. In healthcare, M2SYS has commercialized RightPatient, a biometric patient identification solution designed to reduce duplicate records, medical identity fraud, and patient misidentification. Beyond healthcare, the company now emphasizes AI-powered zero-code software platforms for government agencies and public-sector digital transformation. It is not a drug developer or therapeutics company, but it is healthcare-related through commercial health IT and patient safety offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M2SYS.